Loading company…
RISA Labs automates oncology clinical workflows, including prior authorization processes.
Founded in 2024 and based in San Francisco, US, RISA Labs develops AI workflow automation for oncology providers. Its tools support eligibility checks, medical necessity verification, and prior authorization submissions. In January 2026, it raised USD 11.1 million in Series A funding co-led by Cencora Ventures and Optum Ventures, with Oncology Ventures and Z21 Ventures participating. The funding will support expansion of its AI operating system for oncology.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in